Anti-NO action of carvedilol in cell-free system and in vascular endothelial cells

This publication has 20 references indexed in Scilit:

• A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay
  Published by Elsevier ,2002
• Neuroprotective activities of carvedilol and a hydroxylated derivative: Role of membrane biophysical interactions
  Biochemical Pharmacology, 1998
• Nonenzymatic Nitric Oxide Production in Humans
  Nitric Oxide, 1998
• Development of a Fluorescent Indicator for Nitric Oxide Based on the Fluorescein Chromophore.
  CHEMICAL & PHARMACEUTICAL BULLETIN, 1998
• Quenching of Nitric Oxide by an Oral Carbonaceous Adsorbent.
  The Japanese Journal of Pharmacology, 1997
• A hydroxylated analog of the β-adrenoceptor antagonist, carvedilol, affords exceptional antioxidant protection to postischemic rat hearts
  Free Radical Biology & Medicine, 1996
• The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
  New England Journal of Medicine, 1996
• A sensitive new bioassay for tumor necrosis factor
  Journal of Immunological Methods, 1994
• Antagonistic action of imidazolineoxyl N-oxides against endothelium-derived relaxing factor/.bul.NO (nitric oxide) through a radical reaction
  Biochemistry, 1993
• Hyaluronic acid synthesis is absent in normal human endothelial cells irrespective of hyaluronic acid synthetase inhibitor activity, but is significantly high in transformed cells
  Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1991